Back to search

Phase II Trial of Piritrexim and DTIC Using an Alternating Dose Schedule in Metastatic Melanoma

Data up to Jan 2025

Published1995
Citations7
References0

Total Citations Per Year

Abstract

References (0)

No references found

Cited By (0)

Loading...
Phase II Trial of Piritrexim and DTIC Using an Alternating Dose Schedule in Metastatic… (1995) – American Journal of Clinical Oncology | Metascience Observatory Explorer